NCT01366144 2026-04-13
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
University of Miami
Ohio State University Comprehensive Cancer Center
Valerio Therapeutics
Rigshospitalet, Denmark
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
SCRI Development Innovations, LLC
Fox Chase Cancer Center